Bangkok Genomics Innovation PCL (BKK:BKGI) EV-to-Revenue : 19.25 (As of Jun. 10, 2024)

View and export this data going back to 2024. Start your Free Trial

What is Bangkok Genomics Innovation PCL EV-to-Revenue?

EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, Bangkok Genomics Innovation PCL's enterprise value is ฿1,315.51 Mil. Bangkok Genomics Innovation PCL's Revenue for the trailing twelve months (TTM) ended in Mar. 2024 was ฿68.32 Mil. Therefore, Bangkok Genomics Innovation PCL's EV-to-Revenue for today is 19.25.

The historical rank and industry rank for Bangkok Genomics Innovation PCL's EV-to-Revenue or its related term are showing as below:

BKK:BKGI' s EV-to-Revenue Range Over the Past 10 Years
Min: 5.74 Med: 6.88 Max: 18.68
Current: 19.25

During the past 5 years, the highest EV-to-Revenue of Bangkok Genomics Innovation PCL was 18.68. The lowest was 5.74. And the median was 6.88.

BKK:BKGI's EV-to-Revenue is ranked worse than
88.64% of 220 companies
in the Medical Diagnostics & Research industry
Industry Median: 3.02 vs BKK:BKGI: 19.25

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

As of today (2024-06-10), Bangkok Genomics Innovation PCL's stock price is ฿2.82. Bangkok Genomics Innovation PCL's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2024 was ฿0.15. Therefore, Bangkok Genomics Innovation PCL's PS Ratio for today is 19.32.

Bangkok Genomics Innovation PCL EV-to-Revenue Historical Data

The historical data trend for Bangkok Genomics Innovation PCL's EV-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bangkok Genomics Innovation PCL EV-to-Revenue Chart

Bangkok Genomics Innovation PCL Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Dec23

EV-to-Revenue

Bangkok Genomics Innovation PCL Quarterly Data
	Dec20	Dec21	Mar22	Dec22	Mar23	Dec23	Mar24
EV-to-Revenue	Get a 7-Day Free Trial			-	-	-	-	24.17

Competitive Comparison of Bangkok Genomics Innovation PCL's EV-to-Revenue

For the Diagnostics & Research subindustry, Bangkok Genomics Innovation PCL's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Bangkok Genomics Innovation PCL's EV-to-Revenue Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Bangkok Genomics Innovation PCL's EV-to-Revenue distribution charts can be found below:

* The bar in red indicates where Bangkok Genomics Innovation PCL's EV-to-Revenue falls into.

Bangkok Genomics Innovation PCL EV-to-Revenue Calculation

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

Bangkok Genomics Innovation PCL's EV-to-Revenue for today is calculated as:

EV-to-Revenue	=	Enterprise Value (Today)	/	Revenue (TTM)
	=	1315.506	/	68.321
	=	19.25

Bangkok Genomics Innovation PCL's current Enterprise Value is ฿1,315.51 Mil.
Bangkok Genomics Innovation PCL's Revenue for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ฿68.32 Mil.

Bangkok Genomics Innovation PCL (BKK:BKGI) EV-to-Revenue Explanation

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

Bangkok Genomics Innovation PCL's PS Ratiofor today is calculated as:

PS Ratio	=	Share Price (Today)	/	Revenue per Share (TTM)
	=	2.82	/	0.146
	=	19.32

Bangkok Genomics Innovation PCL's share price for today is ฿2.82.
Bangkok Genomics Innovation PCL's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ฿0.15.

Bangkok Genomics Innovation PCL EV-to-Revenue Related Terms

Thank you for viewing the detailed overview of Bangkok Genomics Innovation PCL's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Bangkok Genomics Innovation PCL (BKK:BKGI) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Bangkok Genomics Innovation PCL (BKK:BKGI) » Definitions » EV-to-Revenue

Comparable Companies

Traded in Other Exchanges

N/A

Address

3689 Rama 4 Road, Phra Khanong Subdistrict, Khlong Toei Subdistrict, Bangkok, THA, 10110

Website

https://www.bangkokgenomics.com

Bangkok Genomics Innovation PCL operate a laboratory and provide medical analysis services. Its services includes Screening for genetic abnormalities in reproductive health (Reproductive Health Testing Services),Infectious Disease Analysis Product Group (Infectious - Related Testing Services), Other screening product groups (Other Testing Services), providing technology services (Tech Solution Services), and Sales of other medical products Related (Medical - Related Products).